1-2 of 2
Dirk Jaeger
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Diarrhea Is a Positive Outcome Predictor for Sorafenib Treatment of Advanced Hepatocellular Carcinoma

Available to Purchase
Subject Area:
Oncology
Ronald Koschny, Daniel Gotthardt, Christiane Koehler, Dirk Jaeger, Wolfgang Stremmel, Tom M. Ganten
Journal: Oncology
Oncology (2012) 84 (1): 6–13.
https://doi.org/10.1159/000342425
Published Online: 13 October 2012
View articletitled, Diarrhea Is a Positive Outcome Predictor for Sorafenib Treatment of Advanced Hepatocellular Carcinoma
Open the PDF for Diarrhea Is a Positive Outcome Predictor for Sorafenib Treatment of Advanced Hepatocellular Carcinoma in another window
Journal Articles

Short Time to Progression under First-Line Chemotherapy Is a Negative Prognostic Factor for Time to Progression and Residual Survival under Second-Line Chemotherapy in Advanced Pancreatic Cancer

Available to Purchase
Subject Area:
Oncology
Christina Herrmann, Ulrich Abel, Wolfgang Stremmel, Dirk Jaeger, Thomas Herrmann
Journal: Oncology
Oncology (2008) 73 (5-6): 335–339.
https://doi.org/10.1159/000134477
Published Online: 23 May 2008
View articletitled, Short Time to Progression under First-Line Chemotherapy Is a Negative Prognostic Factor for Time to Progression and Residual Survival under Second-Line Chemotherapy in Advanced Pancreatic Cancer
Open the PDF for Short Time to Progression under First-Line Chemotherapy Is a Negative Prognostic Factor for Time to Progression and Residual Survival under Second-Line Chemotherapy in Advanced Pancreatic Cancer in another window